# A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR

> **NCT02735369** · PHASE2 · TERMINATED · sponsor: **OcuCure Therapeutics, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Proliferative Diabetic Retinopathy (PDR)

## Interventions

- **DRUG:** 2% OC-10X
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02735369
- **Lead sponsor:** OcuCure Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02735369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02735369, "A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02735369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*